Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-22-003398
Filing Date
2022-06-22
Accepted
2022-06-22 16:29:02
Documents
1
Period of Report
2022-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4061
  Complete submission text file 0001179110-22-003398.txt   5672
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNE DESIGN CORP. 1616 EASTLAKE AVE. E, SUITE 310 SEATTLE WA 98102
Business Address
Brady Stephen R (Reporting) CIK: 0001606241 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 221032386